First-In-Human Study Of Camidanlumab Tesirine (Adct-301, Cami), An Anti-Cd25 Targeted Therapy In Patients (Pts) With Advanced Solid Tumours: Pharmacokinetics (Pk) And Biomarker Evaluation

I. Puzanov, K. Havenith,J. Boni, H. G. Cruz,K. Anderson, T. Kopotsha, Y. Le Bruchec, J. C. Bendell,S. Kummar, K. P. Papadopoulos,P. Lorusso, J. Wuerthner

Annals of Oncology(2020)

引用 2|浏览32
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要